Introduction
============

Autoimmune thyroid disease (AITD) affects approximately 5% of the general population ([@B23]; [@B10]). Graves' disease (GD) and Hashimoto's thyroiditis (HT) are two main subtypes of AITD and mainly characterized by thyrotoxicosis and hypothyroidism, respectively ([@B4]). Although GD and HT present different clinical phenotypes, both diseases share common immunopathogenic features, including lymphocytic infiltration of the thyroid and the production of thyroid autoantibodies ([@B24]), suggesting that immune-modulating genes participate in the occurrence of AITD. During the last several decades, great progress has been made in the study of AITD risk factors. Epidemiological studies have pointed out several environmental factors triggering AITD, such as viral infections, drugs, irradiation and iodine intake, which probably involve interference with thyroid function, immune stimulation, direct toxic effects on thyrocytes, or other immunomodulatory effects ([@B18]; [@B1]). Furthermore, increasing evidences have suggested that individual genetic factors also play an important role in the risk of AITD ([@B2]; [@B5]; [@B17]). The exploration of genetic factors associated with AITD risk will contribute to risk assessment and prevention of disease.

Signal transducer and activator of transcription 4 (*STAT4*) gene, located on human chromosome 2q32.3, encodes a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor related kinases, and then form homo- or heterodimers that translocate to the cell nucleus in which they function as transcription activators ([@B25]). This protein is responsible for mediating responses to interleukin-12 (IL12) in lymphocytes, and regulating the production of interferon-γ (IFN-γ) and the differentiation of T-helper type 1 (Th1) cells ([@B22]; [@B12]; [@B15]). Therefore it is an important mediator of the immune response and it is highly plausible that any change in *STAT4* expression or activity can alter the function and response of the normal immune system, leading to immunosuppression or autoimmune disorders.

Single nucleotide polymorphism (SNP) was the most common type of genetic variations in human genome. Some potentially functional SNPs have been reported to be associated with the risk of human complex diseases, such as cancer, schizophrenia, stroke, AITD ([@B19]; [@B7]; [@B6]; [@B20]; [@B27]). Thereinto a SNP (rs7574865 G/T) located in the third intron of *STAT4* gene is worthy of being noted. Although it is not located in the promoter or 3^′^-untranslated region, it can influence *STAT4* expression. Compared to rs7574865 G allele, the presence of T allele can significantly enhance *STAT4* mRNA transcription and protein expression ([@B11]; [@B16]). Even though the molecular mechanism of the SNP is unclear, it has been linked to the susceptibility of numerous autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis and AITD ([@B13]; [@B14]; [@B8]). For the association of *STAT4* rs7574865 polymorphism with AITD susceptibility, some inconsistent results were reported. For instance, some studies argued that rs7574865 polymorphism was significantly associated with AITD susceptibility, but others showed no significant association, which might be due to a small sample size in a single study ([@B3]; [@B19]; [@B26]; [@B9]; [@B28]). In order to draw a more reliable conclusion, we performed a pooled analysis of data from all relevant studies.

Materials and Methods {#s1}
=====================

Literature Retrieval Strategy
-----------------------------

Embase, PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) electronic databases were searched for eligible studies published till August 20, 2018. The following terms were used for searching titles or abstracts: "*STAT4* OR Signal transducer and activator of transcription 4," "polymorphism OR SNP OR variation" and "autoimmune thyroid disease OR AITD". In addition, the original or review reports were screened carefully and searched manually for more eligible studies based on their references.

Study Selection
---------------

Eligible studies were chosen by two authors independently (XR Gao and JG Wang) according to the following inclusion criteria: (i) case-control studies that assessed the relationship between *STAT4* rs7574865 polymorphism and AITD susceptibility; (ii) studies that contained the distribution of allelic or genotypic frequencies of *STAT4* rs7574865 polymorphism in all participants; (iii) studies that scored more than six stars based on the Newcastle-Ottawa Scale (NOS), which was adopted to assess the methodological quality of each candidate study ([@B21]). The NOS comprised three assessment categories, including comparability, exposure and selection, which contained one, three, and four items, respectively. In the selection and exposure categories, each eligible item was endowed with one star, and in the comparability category, eligible item was endowed with at most two stars.

Data Extraction
---------------

Two investigators (XR Gao and JG Wang) independently extracted data from each eligible literature, including first author's name, publication year, country of origin, ethnicity, genotyping method, the total number of participants, allelic or genotypic frequencies, and *P* value for Hardy-Weinberg equilibrium (HWE). Any controversial content would be resolved by discussing with a third author (YG Yu).

Statistical Analysis
--------------------

Hardy-Weinberg equilibrium status of the controls was measured by the goodness-of-fit chi-square test. *P*~HWE~ value \> 0.05 indicated that the genotype frequency of the controls was consistent with HWE. Chi-square based Q statistic were used to evaluate heterogeneity between studies. If *P*~Q~ value \< 0.1, the heterogeneity between studies was significant. Thus, the random-effects model would be adopted to calculate the pooled odds ratios (ORs), otherwise, the fixed-effects model would be chosen. The pooled ORs with 95% confidence intervals (CIs) were used to assess the strength of the association. The statistical significance of the strength was determined by Z-test. *P*~z~ value \< 0.05 was considered statistically significant. A total of five genetic comparison models were used in the present analysis, including homozygote model (TT vs. GG), heterozygous model (TG vs. GG), dominant model \[(TT+TG) vs. GG\], recessive model \[TT vs. (TG+GG)\], and allele comparison model (T vs. G). In addition, the stability of the pooled results and the potential publication bias were evaluated by sensitivity analysis and funnel plots, respectively. All of the above analyses were performed by RevMan 5.0 software (The Cochrane Collaboration, Copenhagen).

Results
=======

Characteristics of Studies
--------------------------

A total of 502 articles were originally obtained by literature retrieval. According to our inclusion criteria, 5 articles published between the years 2011 and 2016 were finally included in the present meta-analysis (Figure [1](#F1){ref-type="fig"}). As shown in Table [1](#T1){ref-type="table"}, there were 1707 AITD patients and 2316 controls that were used to assess the relationship between *STAT4* rs7574865 polymorphism and AITD susceptibility. Thereinto, 1548 AITD patients and 2116 controls belonged to Asian population. Other paticipants including 159 AITD patients and 200 controls belonged to African population. For the NOS, all the studies scored more than 6 stars, and were considered to be of high methodological quality (Supplementary Table [S1](#SM3){ref-type="supplementary-material"}).

![Flow diagram of literature retrieval and selection process.](fgene-09-00708-g001){#F1}

###### 

The main characteristics of the included studies.

  Authors   Year   Country   Ethnicity   Genotyping methods   Cases   Controls   PHWE   NOS                                              
  --------- ------ --------- ----------- -------------------- ------- ---------- ------ ------ ------ ----- ------ ---- --------- ------ ---------
  [@B28]    2016   China     Asian       Sequencing           26      15         20     61     GD     23    22     5    50        0.94   7 stars
  [@B9]     2015   Turkey    Asian       real time PCR        13      2          0      15     AITD   59    39     5    103       0.65   8 stars
  [@B26]    2014   China     Asian       PCR-LDR              427     474        143    1044   AITD   408   404    91   903       0.54   8 stars
                                                              287     304        99     690    GD                                        
                                                              140     170        44     354    HT                                        
  [@B19]    2011   Korea     Asian       TaqMan               367     61         428    AITD   954    106   1060   NA   8 stars          
                                                              208     33         241    GD                                               
                                                              159     28         187    HT                                               
  [@B3]     2011   Tunisia   African     TaqMan               102     50         7      159    AITD   135   63     2    200       0.07   8 stars
                                                                                                                                         

AITD, autoimmune thyroid disease; GD, Graves' disease; HT, Hashimoto's thyroiditis; NA, not available.

Quantitative Synthesis
----------------------

The association of *STAT4* rs7574865 polymorphism with AITD susceptibility was shown in Table [2](#T2){ref-type="table"} and Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}. The overall pooled analysis indicated that *STAT4* rs7574865 polymorphism was significantly associated with AITD susceptibility \[TT vs. GG: OR = 1.63, 95%CI = 1.24--2.15, *P*~Z~ = 0.0005; TT vs. (TG+GG): OR = 1.55, 95%CI = 1.26--1.91, *P*~Z~ \< 0.0001\]. The subgroup analysis based on ethnicity showed a significant association of *STAT4* rs7574865 polymorphism with AITD susceptibility in Asian population \[TT vs. GG: OR = 1.57, 95%CI = 1.18--2.08, *P*~Z~ = 0.002; TT vs. (TG+GG): OR = 1.51,95%CI = 1.23--1.87, *P*~Z~ = 0.0001\], but not in African population. The stratified analysis by disease type showed that *STAT4* rs7574865 polymorphism was significantly associated both with GD \[TT vs. (TG+GG): OR = 1.57, 95%CI = 1.24--2.00, *P*~Z~ = 0.0002\] and HT susceptibility \[TT vs. (TG+GG): OR = 1.39, 95%CI = 1.04--1.86, *P*~Z~ = 0.03\].

###### 

The association between *STAT4* rs7574865 polymorphism and AITD susceptibility.

  Comparison model          Subgroup   No. of studies   Sample size (Cases/Controls)   *P*~H~   Effect model   OR (95% CI)               *P*~Z~
  ------------------------- ---------- ---------------- ------------------------------ -------- -------------- ------------------------- --------------
  Homozygote comparison     AITD       4                738/728                        0.20     Fixed          **1.63 \[1.24, 2.15\]**   **0.0005**
  (TT vs. GG)               Asian      3                629/591                        0.23     Fixed          **1.57 \[1.18, 2.08\]**   **0.002**
                            African    1                109/137                        --       --             4.63 \[0.94, 22.77\]      0.06
  Heterozygote comparison   AITD       4                1109/1153                      0.13     Fixed          1.05 \[0.89, 1.25\]       0.54
  (TG vs. GG)               Asian      3                957/955                        0.06     Random         0.71 \[0.33, 1.52\]       0.37
                            African    1                152/198                        --       --             1.05 \[0.67, 1.65\]       0.83
  Dominant model            AITD       4                1279/1256                      0.18     Fixed          1.15 \[0.98, 1.35\]       0.09
  \[(TT+TG) vs. GG\]        Asian      3                1120/1056                      0.08     Random         0.93 \[0.49, 1.77\]       0.83
                            African    1                159/200                        --       --             1.16 \[0.75, 1.80\]       0.51
  Recessive model           AITD       5                1707/2316                      0.18     Fixed          **1.55 \[1.26, 1.91\]**   **\<0.0001**
  \[TT vs. (TG+GG)\]        HT         2                541/1963                       0.46     Fixed          **1.39 \[1.04, 1.86\]**   **0.03**
                            GD         3                992/2013                       0.14     Fixed          **1.57 \[1.24, 2.00\]**   **0.0002**
                            Asian      4                1548/2116                      0.22     Fixed          **1.51 \[1.23, 1.87\]**   **0.0001**
                            African    1                159/200                        --       --             4.56 \[0.93, 22.26\]      0.06
  Allele comparison         AITD       4                2558/2512                      0.08     Random         1.22 \[0.89, 1.67\]       0.23
  (T vs. G)                 Asian      3                2240/2112                      0.04     Random         1.12 \[0.62, 2.01\]       0.72
                            African    1                318/400                        --       --             1.25 \[0.86, 1.83\]       0.25
                                                                                                                                         

P

H

, P value for heterogeneity. Bold terms indicate significant OR.

Sensitivity Analysis and Publication Bias
-----------------------------------------

Sensitivity analysis was conducted by removing a single study at a time and reanalyzing the pooled results. The results of the analysis indicated that the omission of any one study could not substantially change the overall pooled results under homozygote comparison (TT vs. GG), heterozygous comparison (TG vs. GG), and recessive comparison \[TT vs. (TG+GG)\] models. However, under dominant comparison \[(TT+TG) vs. GG\] and allele comparison (T vs. G) models, significant changes were observed after removing Hiz's study (Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}). The results of the funnel plots did not show any significant asymmetry in the overall analysis, suggesting a lack of publication bias (Figure [2](#F2){ref-type="fig"}).
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Discussion
==========

In recent years, the association of *STAT4* rs7574865 polymorphism with AITD susceptibility has attracted a lot of attention. Although this polymorphism is located in the non-coding region of *STAT4* gene, it can significantly affect *STAT4* expression and is frequently considered to be related to AITD susceptibility ([@B19]; [@B26]; [@B9]; [@B28]). [@B28] analyzed distribution of the genotype and allele frequency of *STAT4* rs7574865 polymorphism in a Chinese Han Population of Shanxi including 61 GD patients and 50 healthy controls, and found that *STAT4* rs7574865 T allele significantly increased the risk of GD. [@B9] observed that *STAT4* rs7574865 T allele increased AITD susceptibility in a Turkish population containing 15 AITD cases and 103 controls. [@B26] also investigated the role of the *STAT4* rs7574865 polymorphism in AITD susceptibility by a Chinese case-control study (1044 patients affected with AITD and 903 healthy controls), and the results indicated that the frequencies of *STAT4* rs7574865 genotypes in GD patients were significantly different from that in the controls, and the T allele frequency of GD patients was also significantly higher than the controls. [@B19] found that compared with individuals carrying GT and GG gentypes, individuals carrying TT gentypes had an incresed risk of AITD in Korean samples of 428 AITD and 1060 controls. All of the above results suggested that *STAT4* rs7574865 polymorphism could act as a genetic risk factor of AITD. However, a case-control study (159 patients affected with AITD and 200 healthy controls) based on Tunisian population showed no significant association of *STAT4* rs7574865 polymorphism with the risk of AITD ([@B3]). Thus, it is urgent for us to take effective measures to get robust conclusions. Meta-analysis is a very powerful tool for analyzing cumulative data of studies where the sample sizes are small and the statistical power is low. In the present study, we adopted the scientific method to assess the association of *STAT4* rs7574865 polymorphism with AITD susceptibility, and observed that *STAT4* rs7574865 polymorphism was significantly associated with AITD susceptibility. In addition, the subgroup analysis based on ethnicity showed a significant association of *STAT4* rs7574865 polymorphism with AITD susceptibility in Asian population, but not in African population. The stratified analysis based on disease type indicated that *STAT4* rs7574865 polymorphism was significantly related to the susceptibility of both GD and HT.

The present results provided a stronger evidence for the association between *STAT4* rs7574865 polymorphism and AITD susceptibility, but some existing limitations should not be ignored. Firstly, due to a limited number of related studies, we could not assess the association of rs7574865 polymorphism with AITD susceptibility among other ethnicities, such as Caucasians. Secondly, the sample size in the study was small, which reduced the clinical impact of the results. Therefore, further studies with larger sample sizes and other ethnicities are still required to confirm the current findings. Last but not least, our meta-analysis was based on an unadjusted assessment. A more precise analysis should be carried out if personal data such as gender, lifestyle and environmental exposure factors were available.

Conclusion
==========

This meta-analysis showed a significant association between *STAT4* rs7574865 polymorphism and AITD susceptibility, especially in Asian population. The polymorphism may be used as a predictive marker for AITD predisposition.
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Forest plots of the association of *STAT4* rs7574865 polymorphism with the susceptibility of autoimmune thyroid disease.
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Forest plots of the association of *STAT4* rs7574865 polymorphism with the susceptibility of autoimmune thyroid disease after removing Hiz's study.
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The quality assessment of all included studies based on the Newcastle-Ottawa Scale.
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